Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Chang, Ying-Jun  [Clear All Filters]
2018
Chang Y-J, Xu L-P, Wang Y, Zhang X-H, Chen H, Chen Y-H, Wang F-R, Han W, Sun Y-Q, Yan C-H, et al. Effects of low-dose glucocorticoid prophylaxis on chronic GVHD and GVHD-free, relapse-free survival after haploidentical transplantation: long-term follow-up of a controlled, randomized open-label trial. Biol Blood Marrow Transplant. 2018.
Huo M-R, Xu Y-J, Zhai S-Z, Lv M, Wang Y, Cao L-Q, Xu L-P, Zhang X-H, Chen H, Chen Y-H, et al. Prevalence and risk factors of antibodies to human leukocyte antigens in haploidentical stem cell transplantation candidates: A multi-center study. Hum Immunol. 2018.
2016
Guo Z-P, Wang T, Xu L-P, Zhang X-H, Wang Y, Huang X-J, Chang Y-J. Factors affecting the CD34(+) cell yields from the second donations of healthy donors: The steady-state lymphocyte count is a good predictive factor. Transfus Apher Sci. 2016.
Wang Y-T, Kong Y, Song Y, Han W, Zhang Y-Y, Zhang X-H, Chang Y-J, Jiang Z-F, Huang X-J. Increased type 1 immune response in the bone marrow immune microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2016.
Tian D-M, Wang Y, Zhang X-H, Liu K-Y, Huang X-J, Chang Y-J. Rapid Recovery of CD3+CD8+ T Cells on Day 90 Predicts Superior Survival after Unmanipulated Haploidentical Blood and Marrow Transplantation. PLoS One. 2016;11(6):e0156777.
2014
Luo X-H, Chang Y-J, Huang X-J. Improving Cytomegalovirus-Specific T Cell Reconstitution after Haploidentical Stem Cell Transplantation. J Immunol Res. 2014;2014:631951.
Lv M, Zhao X-S, Hu Y, Chang Y-J, Zhao X-Y, Kong Y, Zhang X-H, Xu L-P, Liu K-Y, Huang X-J. Monocytic and Promyelocytic Myeloid-derived suppressor cells may contribute to G-CSF-induced immune tolerance in haplo-identical allogeneic hematopoietic stem cell transplantation. Am J Hematol. 2014.

Pages